Cargando…

Zoledronic Acid as an Adjuvant Therapy in Patients with Breast Cancer: A Systematic Review and Meta-Analysis

BACKGROUND: Zoledronic acid is widely used as adjuvant chemotherapy for the treatment of breast cancer. However, previous trials reported inconsistent findings regarding their clinical efficacy and safety. We carried out a comprehensive systematic review and meta-analysis to evaluate the effects of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Wei-Wei, Huang, Cheng, Liu, Jian, Zheng, Hong-Yu, Lin, Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3406041/ https://www.ncbi.nlm.nih.gov/pubmed/22844410 http://dx.doi.org/10.1371/journal.pone.0040783

Ejemplares similares

Adjuvant zoledronic acid therapy for patients with early stage breast cancer: an updated systematic review and meta-analysis
por: He, Mingfeng, et al.
Publicado: (2013)

Innegligible musculoskeletal disorders caused by zoledronic acid in adjuvant breast cancer treatment: a meta-analysis
por: Zhou, Wen-Bin, et al.
Publicado: (2011)

Identifying therapeutic biomarkers of zoledronic acid by metabolomics
por: Li, Xiang, et al.
Publicado: (2023)

Zoledronic acid inhibits osteoclast differentiation and function through the regulation of NF-κB and JNK signalling pathways
por: Huang, Xiao-Lin, et al.
Publicado: (2019)

Unilateral anterior uveitis complicating zoledronic acid therapy in breast cancer
por: El Saghir, Nagi S, et al.
Publicado: (2005)

Do disease status and race affect the efficacy of zoledronic acid in patients with prostate cancer? A systematic review and meta-analysis of randomized control trials
por: Chen, Chiwei, et al.
Publicado: (2022)

Evaluation of disseminated tumor cells and circulating tumor cells in patients with breast cancer receiving adjuvant zoledronic acid
por: Vidula, Neelima, et al.
Publicado: (2021)

Management of bone metastasis with zoledronic acid: A systematic review and Bayesian network meta-analysis
por: Lorange, Justin-Pierre, et al.
Publicado: (2023)

Effect of (Neo)adjuvant zoledronic acid on disease-free and overall survival in clinical stage II/III breast cancer
por: Aft, R L, et al.
Publicado: (2012)

The evolving role of zoledronic acid in early breast cancer
por: Gnant, Michael
Publicado: (2009)

Systematic review and meta-analysis comparing zoledronic acid administered at 12-week and 4-week intervals in patients with bone metastasis
por: Cao, Ling, et al.
Publicado: (2017)

Effects of Systemic or Local Administration of Zoledronate on Implant Osseointegration: A Preclinical Meta-Analysis
por: He, Yao, et al.
Publicado: (2019)

Dose-dependent inhibitory effects of zoledronic acid on osteoblast viability and function in vitro
por: HUANG, XIN, et al.
Publicado: (2016)

Zoledronic acid blocks the interaction between breast cancer cells and regulatory T-cells
por: Liu, Hsien, et al.
Publicado: (2019)

Preventive effect of zoledronic acid on aromatase inhibitor-associated bone loss for postmenopausal breast cancer patients receiving adjuvant letrozole
por: Sun, Shengliang, et al.
Publicado: (2016)

Reproductive hormone analyses and effects of adjuvant zoledronic acid in early breast cancer – An AZURE (BIG 01/04) sub-study
por: Wilson, Caroline, et al.
Publicado: (2016)

SUBTROCHANTERIC FRACTURE IN A PATIENT RECEIVING ZOLEDRONIC ACID THERAPY FOR METASTATIC BREAST CANCER
por: KISHIMOTO, YASUZUMI, et al.
Publicado: (2011)

Correction: Systematic review and meta-analysis comparing zoledronic acid administered at 12-week and 4-week intervals in patients with bone metastasis
por: Cao, Ling, et al.
Publicado: (2018)

Cost-Effectiveness of Sequential Teriparatide/Zoledronic Acid Compared With Zoledronic Acid Monotherapy for Postmenopausal Osteoporotic Women in China
por: You, Ruxu, et al.
Publicado: (2022)

Cost-Effectiveness of Sequential Denosumab/Zoledronic Acid Compared With Zoledronic Acid Monotherapy for Postmenopausal Osteoporotic Women in China
por: You, Ruxu, et al.
Publicado: (2022)

Zoledronic Acid May Reduce Intraoperative Bleeding in Spinal Tumors: A Prospective Cohort Study
por: Wu, Juan, et al.
Publicado: (2015)

Adjuvant and Salvage Radiotherapy after Prostatectomy: A Systematic Review and Meta-Analysis
por: Chen, Changhao, et al.
Publicado: (2014)

Zoledronic acid inhibits osteoclastogenesis and bone resorptive function by suppressing RANKL-mediated NF-κB and JNK and their downstream signalling pathways
por: Huang, Xiao-Lin, et al.
Publicado: (2022)

Clinical efficacy of zoledronic acid combined with percutaneous kyphoplasty in the prevention and treatment of osteoporotic vertebral compression fracture: A systematic review and meta-analysis
por: Li, Kaiming, et al.
Publicado: (2021)

Cryoablation combined with zoledronic acid in comparison with cryoablation and zoledronic acid alone in the treatment of painful bone metastases
por: LI, FENQIANG, et al.
Publicado: (2014)

Protection of bone in premenopausal women with breast cancer: focus on zoledronic acid
por: Aft, Rebecca
Publicado: (2012)

Dosing of zoledronic acid with its anti-tumor effects in breast cancer
por: Zhao, Xinmin, et al.
Publicado: (2015)

Zoledronic acid ameliorates the effects of secondary osteoporosis in rheumatoid arthritis patients
por: Xie, Jun, et al.
Publicado: (2019)

Natural history of stage II/III breast cancer, bone metastasis and the impact of adjuvant zoledronate on distribution of recurrences
por: D'Oronzo, Stella, et al.
Publicado: (2021)

Oestradiol Contributes to Differential Antitumour Effects of Adjuvant Zoledronic Acid Observed Between Pre- and Post-Menopausal Women
por: Canuas-Landero, Victor G., et al.
Publicado: (2021)

The anti-tumour effects of zoledronic acid
por: Zekri, Jamal, et al.
Publicado: (2014)

Zoledronic Acid–Induced Interface Dermatitis
por: Succaria, Farah, et al.
Publicado: (2015)

Optimal adjuvant therapy for resected hepatocellular carcinoma: a systematic review with network meta-analysis
por: Zhu, Gui-Qi, et al.
Publicado: (2015)

Zoledronic acid sequential to teriparatide may promote greater inhibition of bone resorption than zoledronic acid alone
por: Giveon, Sharon, et al.
Publicado: (2023)

Risk of New Vertebral Fracture and Combination Therapy with Zoledronic Acid and Teriparatide in Diabetic Patients after Percutaneous Kyphoplasty
por: Zhang, Jian, et al.
Publicado: (2021)

Safety & Efficacy of Cyclic Zoledronic Acid Therapy on Pediatric Secondary Osteoporosis
por: Al-Agha, Abdulmoein E., et al.
Publicado: (2016)

Single Dose Therapy of Zoledronic Acid for the Treatment of Transient Osteoporosis of Hip
por: Agarwala, Sanjay, et al.
Publicado: (2019)

Does Dexmedetomidine as a Neuraxial Adjuvant Facilitate Better Anesthesia and Analgesia? A Systematic Review and Meta-Analysis
por: Wu, Huang-Hui, et al.
Publicado: (2014)

Hepatotoxicity induced by zoledronic acid in an aged woman with primary osteoporosis
por: Lu, Yanhui, et al.
Publicado: (2013)

Moxibustion as an Adjuvant Therapy for Cancer Pain: A Systematic Review and Meta-Analysis
por: Li, Yan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_a5k79eut1rgs1b91utv85o4lmv